Site updated at Wednesday, 22 June 2016

Living with Dementia

Alzheimer Treatment

India’s Piramal buys Bayer’s potential Alzheimer drug

Indian drugmaker Piramal Healthcare has agreed to buy a research and development portfolio from Bayer AG, the company said, in a deal that gives Piramal rights to florbetaben, a possible Alzheimer treatment.

Florbetaben, which is in the final stages of clinical trials, works by detecting symptoms in probable sufferers of Alzheimer’s, and is expected… India’s Piramal buys Bayer’s potential Alzheimer drug   

Parkinson’s Disease Dementia

mentally weak1 - mild dementia2 - alzheimer's experience1 - ataxia4 - mixed forms1 - memory tests1 - deep-brain stimulation3 - tuberculosis1 - national academy on an aging society1 - frontotemporal dementia symptoms1 - mental decline2 - hippocampus6 - loss of neuronal connections1 - amyloid1 - amyloid beta peptide1 - memory decline2 - creutzfeldt-jakob disease5 - temporal orientation1 - aortic valve stenosis2 - parkinson's disease protein1 - disorientation3 - alzheimer's disease195 - lipitor1 - restlessness1 - cotard's syndrome1 - ucla1 - american academy of neurology3 - bonfiglio1 - cognitive testing2 - prichard1 -